Sign Up to like & get
recommendations!
0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000030936
Abstract: Protein induced by vitamin K absence or antagonist II (PIVKA-II) is a promising serum marker for hepatocellular carcinoma (HCC). There are limited data on its cutoff value in HCC for Taiwanese cirrhosis patients. This study…
read more here.
Keywords:
vitamin absence;
pivka;
cutoff;
absence antagonist ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Translational cancer research"
DOI: 10.21037/16320
Abstract: Liver transplantation is an important therapy for early-stage hepatocellular carcinoma (HCC). Although patients within the Milan criteria that refer to tumor size ≤5 cm, tumor number ≤3 and no macrovascular invasion has excellent survival outcome,…
read more here.
Keywords:
threshold fetoprotein;
antagonist still;
fetoprotein vitamin;
vitamin absence ... See more keywords